COMBINACION QUE COMPRENDE UN ANTIPSICOTICO Y (2S)-(4E)-N-METIL-5-[3-(5-ISOPROPOXIPIRIDIN)IL]-4-PENTEN-2-AMINA; COMPOSICION FARMACEUTICA QUE LA COMPRENDE; KIT FARMACEUTICO; Y USO PARA TRATAR PERJUICIO COGNITIVO Y/O TRASTORNO PSICOTICOS

COMBINACION QUE COMPRENDE UN ANTIPSICOTICO Y (2S)-(4E)-N-METIL-5-[3-(5-ISOPROPOXIPIRIDIN)IL]-4-PENTEN-2-AMINA; COMPOSICION FARMACEUTICA QUE LA COMPRENDE; KIT FARMACEUTICO; Y USO PARA TRATAR PERJUICIO COGNITIVO Y/O TRASTORNO PSICOTICOS

The present invention provides a combination of (a) an antipsychotic and (b) an alpha4/beta2 (alpha4beta2)-neuronal nicotinic receptor agonist. The invention further relates to pharmaceutical compositions comprising said combination and to the use of the combination in therapy. The invention further...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: EVENDEN JOHN L.,JOHNSON EDWING,MRZLJAK LASILAW,WIDZOWSKI DAN,JORGAN KRISTEN G.,BREINING SCOTT R.,LETCHWORTH SHARON R.,M
Format: Patent
Sprache:spa
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention provides a combination of (a) an antipsychotic and (b) an alpha4/beta2 (alpha4beta2)-neuronal nicotinic receptor agonist. The invention further relates to pharmaceutical compositions comprising said combination and to the use of the combination in therapy. The invention further relates to a kit comprising the combination and use of said kit in therapy.